| Durable Medical Equipment Section - Electrostimulation
and Electromagnetic Therapy for the Treatment of Chronic
Wounds in the Home Setting
| Topic: Electrostimulation and
Electromagnetic Therapy for the Treatment of Chronic
Wounds in the Home Setting |
Date of Origin: 02/03/2004 |
| Section: DME |
Policy No: 67 |
| Approved Date: 07/14/2009 |
Effective Date: 08/01/2009 |
| Next Review Date: 08/2011 |
| |
IMPORTANT REMINDER
Regence Medical Policies are developed to provide guidance for members and providers regarding
coverage in accordance with contract terms. Benefit determinations are based in all cases on
the applicable contract language. To the extent there may be any conflict between the Medical
Policy and contract language, the contract language takes precedence.
PLEASE NOTE: Contracts exclude from coverage, among other things, services or procedures that
are considered investigational or cosmetic. Providers may bill members for services or
procedures that are considered investigational or cosmetic. Providers are encouraged to inform
members before rendering such services that the members are likely to be financially responsible
for the cost of these services.
Description
The normal wound healing process involves inflammatory,
proliferative and remodeling phases. When the healing
process fails to progress properly and the wound persists
for longer than one month, it may be described as a
chronic wound. The types of chronic wounds most frequently
addressed in studies of electrical stimulation for wound
healing are:
- Pressure ulcers
- Venous ulcers
- Arterial ulcers
- Diabetic ulcers
Conventional or standard therapy for chronic wounds
involves local wound care as well as systemic measures
including debridement of necrotic tissues, wound cleansing
and dressing that promote a moist wound environment,
antibiotics to control infection and optimizing nutritional
supplementation. Non-weight bearing is another important
component of wound management. Since the 1950s, investigators
have used electrical stimulation as a technique to promote
wound healing, based on the theory that electrical stimulation
may:
- Increase ATP concentration in the skin
- Increase DNA synthesis
- Attract epithelial cells and fibroblasts to wound
sites
- Accelerate the recovery of damaged neural tissue
- Reduce edema
- Increase blood flow
- Inhibit pathogenesis
Electrical stimulation refers to the application of
electrical current through electrodes placed directly
on the skin in close proximity to the wound. The types
of electrical stimulation and devices can be categorized
into 4 groups based on the type of current:
- Low intensity direct current (LIDC)
- High voltage pulsed current (HVPC)
- Alternating current (AC)
- Transcutaneous electrical nerve stimulation (TENS)
Electromagnetic therapy is a related but distinct form
of treatment that involves the application of electromagnetic
fields rather than direct electrical current.
At the present time there are no electrical stimulation
devices that have received FDA approval specifically
for the treatment of wound healing. A number of devices
have been cleared for marketing for other indications.
Use of these devices for wound healing is an off-label
indication.
Stage III and IV skin ulcers are defined as follows:
Stage III:
Full thickness skin loss involving damage to, or necrosis
of, subcutaneous tissue that may extend down to, but
not through, underlying fascia. The ulcer presents
clinically as a deep crater with or without undermining
of adjacent tissue.
Stage IV:
Full thickness skin loss with extensive destruction,
tissue necrosis or damage to muscle, bone, or other
supporting structures (e.g., tendon, joint capsule).
Undermining and sinus tracts also may be associated
with Stage IV pressure ulcers.
Policy/Criteria
Electrical stimulation and electromagnetic therapy
for the treatment of wounds performed by the patient
in the home setting is considered investigational. All
electrical stimulation devices are included in the
category, including but not limited to, low intensity
direct current, high voltage pulsed current (HVPC),
alternating current (AC) and transcutaneous electrical
nerve stimulation (TENS)*.
*Note: Electrical stimulation
as a treatment of pain and other musculoskeletal conditions
are considered separately in Regence Medical Policies
DME 11, 56, 57, 65, 66, and Surgery 44.
Position Summary
It is unknown whether electrical stimulation or electromagnetic therapy in the home setting without supervision by a healthcare provider improves wound healing compared with conventional wound care techniques.
The current body of evidence in the published literature only addresses the use of electrical stimulation therapy applied and supervised by health care professionals.
References
- BlueCross and BlueShield Association Medical Policy
Reference Manual, Policy No. 2.01.57
Cross References
Electrical
Stimulation Devices for Home Use; Regence Medical
Policy Manual, DME, Policy No. 11
Non-Contact Ultrasound Treatments for Wounds, Regence Medical Policy Manual, Medicine, Pol.icy No. 131
| Codes |
Number |
Description |
| CPT |
None |
|
| HCPCS |
E0761 |
Non-thermal pulsed high frequency radiowaves, high peak power electromagnetic energy treatment device. |
| |
E0769 |
Electrical stimulation or electromagnetic wound
treatment device, not otherwise classified |
| |
G0281 |
Electrical stimulation, (unattended), to one or
more areas, for chronic stage III and stage IV pressure
ulcers, arterial ulcers, diabetic ulcers, and venous
stasis ulcers not demonstrating measurable signs
of healing after 30 days of conventional care, as
part of a therapy plan of care. |
| |
G0282 |
Electrical stimulation, (unattended), to one or
more areas, for wound care other than described
in G0281 |
| |
G0295 |
Electromagnetic stimulation, to one or more
areas, for wound care other than described in
G0329 or for other uses |
| |
G0329 |
Electromagnetic therapy, to one or more areas
for chronic stage III and stage IV pressure ulcers,
arterial ulcers, diabetic ulcers and venous stasis
ulcers not demonstrating measurable signs of healing
after 30 days of conventional care as part of a
therapy plan of care. |
DME Section Table of Contents 

|